Fortfahren mit
EM0200
Osteo-Bed Bone Embedding Kit
Anmelden zur Ansicht der Organisations- und Vertragspreise.
Über diesen Artikel
NACRES:
NA.47
UNSPSC Code:
12171500
Storage temp.:
room temp
application(s)
hematology
histology
storage temp.
room temp
Application
Suitable for use with large and small mineralized (undecalcified) bone sections. Yields clear, hard blocks for cutting sections. Not water-soluble.
Other Notes
Osteo-Bed Bone Embedding Solvent (O8639) is available to remove plastic from sections.
Nur Kit-Komponenten
Produkt-Nr.
Beschreibung
- Osteo-Bed Bone Embedding Resin A (O8514) 900 mL
- Osteo-Bed Bone Embedding Catalyst (O8764) 2 x 12
signalword
Danger
target_organs
Respiratory system
Lagerklasse
5.2 - Organic peroxides and self-reacting hazardous materials
flash_point_f
50.0 °F
flash_point_c
10 °C
Hazard Classifications
Aquatic Acute 1 - Aquatic Chronic 1 - ED ENV 1 - ED HH 1 - Eye Irrit. 2 - Flam. Liq. 2 - Org. Perox. D - Repr. 1B - Skin Irrit. 2 - Skin Sens. 1 - STOT SE 3
Hier finden Sie alle aktuellen Versionen:
Besitzen Sie dieses Produkt bereits?
In der Dokumentenbibliothek finden Sie die Dokumentation zu den Produkten, die Sie kürzlich erworben haben.
Verwandter Inhalt
Instructions
Lei Qin et al.
Journal of orthopaedic translation, 34, 60-72 (2022-05-27)
The key focal adhesion protein β1 integrin plays an essential role in early skeletal development. However, roles of β1 integrin expression in osteocytes during the regulation of bone homeostasis and mechanotransduction are incompletely understood. To study the in vivo function
Kindlin-2 mediates mechanotransduction in bone by regulating expression of Sclerostin in osteocytes.
Lei Qin et al.
Communications biology, 4(1), 402-402 (2021-03-27)
Osteocytes act as mechanosensors in bone; however, the underlying mechanism remains poorly understood. Here we report that deleting Kindlin-2 in osteocytes causes severe osteopenia and mechanical property defects in weight-bearing long bones, but not in non-weight-bearing calvariae. Kindlin-2 loss in
Colin K Yee et al.
Clinical & experimental metastasis, 25(8), 903-911 (2008-09-25)
In the current study, we examine heparin's anti-metastatic properties by using a well-defined mouse model of osteolytic bone metastasis. C57BL/6 mice were treated with increasing doses of unfractionated heparin (15, 20, or 25 units/mouse) 30 min prior to the left
Global Trade Item Number
| SKU | GTIN |
|---|---|
| EM0200-1KT | 04061833609439 |